skip to main content
Life Sciences Practice

Life Sciences Practice

Sophisticated guidance for pharmaceutical, biotechnology and healthcare companies navigating regulatory, transactional and enforcement challenges.

Pharmaceutical, biotechnology and healthcare companies face a complex array of issues and require interdisciplinary legal teams that serve as true partners to their business. Our lawyers have a comprehensive understanding of our clients’ challenges, opportunities and goals and provide sophisticated and precise guidance across a complete spectrum of legal services. 

Mergers and acquisitions, joint ventures, corporate transactions and licensing:

  • Pharmaceutical companies entering or expanding their presence in the US, Europe, Latin America and the Asia-Pacific Basin
  • Issues involving licensed pharmaceutical products, biologics and intellectual property
  • Joint ventures and strategic alliances, specifically including licensing, product development, research and marketing collaborations
  • Transactions involving international performance and regulatory clearances
  • Creation of novel product sourcing and distribution agreements
  • Negotiating and implementing agreements with contracts research organizations


Antitrust:

  • Private antitrust litigation
  • Criminal grand jury inquiries
  • Civil governmental inquiries
  • All phases of Hart-Scott Rodino
  • Post-closing antitrust reviews of collaborations between competitors
  • Antitrust issues attendant to product development, marketing and compliance
  • Development and implementation of corporate compliance programs
  • Advice regarding EU competition rules in both our domestic and Paris offices
  • Competition law and enforcement in the Pacific Basin, South America, and Africa


Litigation, arbitration and dispute resolution:

  • Massive product liability litigation
  • Insurance coverage disputes
  • General civil litigation
  • Corporate reorganization and bankruptcy cases
  • Alternative dispute resolution
  • Pharmaceutical licensing agreements
  • Patent infringement and validity lawsuits for medical and dental device companies
  • False advertising claims under the Lanham Act


Food and drug law: 

  • Representation of multinational research-based pharmaceutical companies
  • Representation of foreign and domestic medical device and cosmetics manufacturers
  • US Food and Drug Administration regulatory matters


US employment law:

  • Development and review of compliance programs
  • Defense in discrimination, wrongful termination and breach of contract cases
  • Employment agreements
  • Negotiation of collective bargaining agreements with local unions 


Government contracts law:

  • Bid protests
  • Post-award audits
  • Enforcement actions
  • Practice before the executive agencies, the General Services Administration, the boards of contract appeals and federal courts
  • Federal Supply Schedule contracting under the Veterans Healthcare Act of 1992

Latest Updates

First Circuit Affirms Dismissal in Biopharmaceutical Investor Litigation

Hughes Hubbard successfully represented Samuel and Nadine Wohlstadter in an appeal before the U.S. Court of Appeals for the First Circuit, which affirmed the dismissal of a securities fraud action ordered by Judge Richard C. Stearns of the U.S. District Court for the District of Massachusetts. Hughes Hubbard’s legal team also represented the Wohlstadters in the District of Massachusetts proceedings.

Jim Kobak Selected to Law360’s Access to Justice Editorial Board

Jim Kobak has been selected to serve on Law360’s 2026 Access to Justice Editorial Board.

Hughes Hubbard Acquires Schulman Bhattacharya, Expanding Litigation and Arbitration Practices in Washington, D.C.

Hughes Hubbard & Reed LLP announced today that it has acquired Schulman Bhattacharya LLC, a premier commercial litigation and arbitration boutique in Washington, D.C.

Sub hero background

Have some more questions? Connect with one of our lawyers.

Stay Up to Date

Sign up to receive practical updates, fresh perspectives and helpful guidance delivered straight to your inbox.

Stay connected for our latest news and insights.

Stay up to Date